Published in Ann Rheum Dis on August 01, 1993
The chemotactic effect of mixtures of antibody and antigen on polymorphonuclear leucocytes. J Exp Med (1962) 23.03
Leukocyte locomotion and chemotaxis. New methods for evaluation, and demonstration of a cell-derived chemotactic factor. J Exp Med (1973) 14.88
Relationship between cyclic guanosine 3':5'-monophosphate formation and relaxation of coronary arterial smooth muscle by glyceryl trinitrate, nitroprusside, nitrite and nitric oxide: effects of methylene blue and methemoglobin. J Pharmacol Exp Ther (1981) 3.14
Cyclic GMP and cell movement. Nature (1973) 2.46
Enhancement of random migration and chemotactic response of human leukocytes by ascorbic acid. J Clin Invest (1974) 1.81
Modulation of human neutrophil chemotactic responses by cyclic 3',5'-guanosine monophosphate and cyclic 3',5'-adenosine monophosphate. Metabolism (1975) 1.78
In vitro stimulation of neutrophil motility by levamisole: maintenance of cgmp levels in chemotactically stimulated levamisole-treated neutrophils. J Immunol (1976) 1.76
The in vitro effects of histamine and metiamide on neutrophil motility and their relationship to intracellular cyclic nucleotide levels. J Immunol (1977) 1.49
1-O-hexadecyl-2-Q-methylglycerol, a novel inhibitor of protein kinase C, inhibits the respiratory burst in human neutrophils. J Biol Chem (1989) 1.24
Neutrophil chemotaxis in rheumatoid arthritis. Effect of D-penicillamine, gold salts, and levamisole. Ann Rheum Dis (1978) 1.24
Leukotrienes in inflammation. Agents Actions (1986) 1.20
Protein kinase C activity appears to be required for the synthesis of platelet-activating factor and leukotriene B4 by human neutrophils. J Biol Chem (1987) 1.16
Inhibition of lysosomal enzyme release from rat leukocytes by auranofin. A new chrysotherapeutic agent. Inflammation (1977) 1.14
LY83583: an agent that lowers intracellular levels of cyclic guanosine 3',5'-monophosphate. J Pharmacol Exp Ther (1985) 1.04
Stimulation of rabbit polymorphonuclear leukocyte locomotion by D-penicillamine. Biochem Pharmacol (1991) 1.03
The stimulation of IL-2 production by anti-rheumatic drugs. Immunology (1989) 1.00
Tiopronin (2-mercaptopropionylglycine) has chemokinetic and chemotactic properties for polymorphonuclear leukocytes. Immunopharmacology (1992) 0.92
Stimulatory effects of anti-rheumatic drugs on human neutrophil functions. Immunopharmacology (1989) 0.87
Auranofin affects early events in human polymorphonuclear neutrophil activation by receptor-mediated stimuli. J Immunol (1984) 0.85
Modulation of neutrophil functions by auranofin. Studies on effects in vitro and in rheumatoid arthritis patients. Scand J Rheumatol (1983) 0.85
Effects of gold coordination complexes on neutrophil function are mediated via inhibition of protein kinase C. Mol Pharmacol (1989) 0.84
Antirheumatic drug effects on neutrophil response to chemotactic factors: a comparison of analytical techniques. Proc Soc Exp Biol Med (1983) 0.83
Interactions of antirheumatic drugs with the superoxide generation system of activated human polymorphonuclear leukocytes. J Rheumatol (1986) 0.82
Auranofin, gold thiomalate, and gold thioglucose inhibit protein kinase C. Biochem Pharmacol (1989) 0.82
Effects of gold compounds on the function of phagocytic cells. I. Suppression of phagocytosis and the generation of chemiluminescence by polymorphonuclear leukocytes. J Rheumatol Suppl (1982) 0.81
Auranofin stimulates LTA hydrolase and inhibits 5-lipoxygenase/LTA synthase activity of isolated human neutrophils. Biochem Pharmacol (1990) 0.81
In vitro and in vivo effects of gold salts on chemotaxis and random migration of rat polymorphonuclear leucocytes. Agents Actions (1985) 0.81
Inhibition of human neutrophils by auranofin: chemotaxis and metabolism of arachidonate via the 5-lipoxygenase pathway. Ann Rheum Dis (1989) 0.78
Auranofin modulates human neutrophil superoxide production and protein phosphorylation. Rheumatol Int (1989) 0.77
Oral chrysotherapy in rheumatoid arthritis: minimum effective dose. J Rheumatol (1980) 0.77
Inhibition of neutrophil migration soon after initiation of treatment with leflunomide or methotrexate in patients with rheumatoid arthritis: findings in a prospective, randomized, double-blind clinical trial in fifteen patients. Arthritis Rheum (2000) 1.13
Stimulation of rabbit polymorphonuclear leukocyte locomotion by D-penicillamine. Biochem Pharmacol (1991) 1.03
Tiopronin (2-mercaptopropionylglycine) has chemokinetic and chemotactic properties for polymorphonuclear leukocytes. Immunopharmacology (1992) 0.92
Glutathione-induced enhancement of neutrophil locomotion. Immunobiology (1991) 0.91
Inhibition of neutrophil migration by guanine nucleotides. Agents Actions (1991) 0.89
Modulation of neutrophil migration by exogenous gaseous nitric oxide. J Leukoc Biol (1996) 0.87
Protamine-induced permeability changes in the neutrophil plasma membrane as the basis of activation of exocytosis. Cell Biochem Funct (1992) 0.85
Inhibition of neutrophil chemotaxis by purinoceptor agonists. Arch Int Pharmacodyn Ther (1993) 0.82
Inhibition of interleukin-8-activated human neutrophil chemotaxis by thapsigargin in a calcium- and cyclic AMP-dependent way. Biochem Pharmacol (2000) 0.82
Carbon monoxide enhances human neutrophil migration in a cyclic GMP-dependent way. Biochem Biophys Res Commun (1996) 0.82
Neutrophil chemotaxis induced by the diacylglycerol kinase inhibitor R59022. Biochim Biophys Acta (1993) 0.81
The effect of cyclic GMP and cyclic AMP on migration by electroporated human neutrophils. Eur J Pharmacol (1993) 0.81
Endothelin-induced activation of neutrophil migration. Biochem Pharmacol (1994) 0.81
An activating and cytotoxic effect of asbestos on polymorphonuclear leukocytes. Agents Actions (1989) 0.80
The effect of pentoxifylline on human neutrophil migration: a possible role for cyclic nucleotides. Biochem Pharmacol (1997) 0.80
Changes of plasma membrane permeability in neutrophils treated with polycations. Inflammation (1991) 0.80
The stimulation of human neutrophil migration by angiotensin IL: its dependence on Ca2+ and the involvement of cyclic GMP. Br J Pharmacol (1997) 0.79
The role of calcium ions in DEAE-dextran-induced stimulation of neutrophil migration. Chem Biol Interact (1995) 0.78
Interaction of cyclic GMP and cyclic AMP during neutrophil migration: involvement of phosphodiesterase type III. Biochem Pharmacol (1998) 0.78
Sodium azide enhances neutrophil migration and exocytosis: involvement of nitric oxide, cyclic GMP and calcium. Life Sci (1998) 0.78
Characterization of exocytosis in electropermeabilized neutrophils by flow cytometric analysis: difference in sensitivity to calcium and guanosine-5'-[gamma-thio]triphosphate. Cytometry (1994) 0.78
The effect of endothelin-2 (ET-2) on migration and changes in cytosolic free calcium of neutrophils. Naunyn Schmiedebergs Arch Pharmacol (1996) 0.78
The role of calcium in neutrophil migration: the effect of calcium and calcium-antagonists in electroporated neutrophils. Biochem Biophys Res Commun (1992) 0.78
Modulation of neutrophil migration by captopril. Naunyn Schmiedebergs Arch Pharmacol (1993) 0.77
Stimulation and inhibition of neutrophil chemotaxis by endothelin-3. J Cardiovasc Pharmacol (1995) 0.77
The effects of photodynamic therapy on human neutrophil migration using bacteriochlorin a. Photochem Photobiol (1998) 0.77
Ryanodine as inhibitor of chemotactic peptide-induced chemotaxis in human neutrophils. Biochem Pharmacol (1995) 0.76
Differential stimulation of neutrophil functions by pyrithioxine. Int J Immunopharmacol (1993) 0.76
Asbestos-induced activation of the respiratory burst in rabbit neutrophils. Res Commun Chem Pathol Pharmacol (1988) 0.76
N-acetylcysteine causes a transient stimulation of neutrophil migration. Immunopharmacology (1998) 0.76
Modulation of human neutrophil chemotaxis by the endothelin-B receptor agonist sarafotoxin S6c. Chem Biol Interact (1996) 0.75
A cyclic GMP- and G-kinase-dependent effect of azathioprine on migration by human neutrophils. Cell Mol Life Sci (1997) 0.75
The involvement of ionic interactions during asbestos-induced enzyme release from polymorphonuclear leukocytes. Chem Biol Interact (1989) 0.75
Cytochalasin-induced nitroblue tetrazolium dye (NBT) reduction in polymorphonuclear leukocytes. Res Commun Chem Pathol Pharmacol (1990) 0.75
The effect of thimerosal on neutrophil migration: a comparison with the effect on calcium mobilization and CD11b expression. Biochem Pharmacol (1998) 0.75
The role of cyclic AMP and protein kinase A in stimulation of neutrophil migration by endothelins. Naunyn Schmiedebergs Arch Pharmacol (1998) 0.75
GTP[S] stimulates migration of electropermeabilized neutrophils via a pertussis toxin-sensitive G-protein. Cell Signal (1993) 0.75
N-methyl-N'-nitro-N-nitrosoguanidine: the effect on migration and cGMP level of neutrophils. Toxicology (1992) 0.75
Chrysotile asbestos-induced membrane damage in human erythrocytes. Res Commun Chem Pathol Pharmacol (1991) 0.75
Exocytosis in neutrophils induced by thapsigargin and other inhibitors of calcium ATP-ase. Res Commun Mol Pathol Pharmacol (1994) 0.75
Activation of neutrophil migration by dioctanoyl-sn-glycerol and fMet-Leu-Phe is controlled by different pathways. Agents Actions (1993) 0.75
Induction of superoxide production in rabbit neutrophils by a stable analogue of GTP. Agents Actions (1990) 0.75
Some little-known hallucinogenic plants of the Aztecs. J Psychoactive Drugs (1989) 0.75
Cytochalasin B-induced superoxide production in polycation-treated neutrophils. Inflammation (1991) 0.75
Cyclic nucleotide-induced migration of electropermeabilized neutrophils: the effect of phosphodiesterase-resistant analogues. Inflamm Res (1997) 0.75
Stimulation of human neutrophil migration by aurothioglucose and thioglucose. Agents Actions (1993) 0.75
Captopril-induced enhancement of fMet-Leu-Phe-activated enzyme secretion from neutrophils. Agents Actions (1993) 0.75